Characterization of a novel Tn6485h transposon carrying both blaIMP-45 and blaAFM-1 integrated into the IncP-2 plasmid in a carbapenem-resistant Pseudomonas aeruginosa.

J Glob Antimicrob Resist

Centre of Laboratory Medicine, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address:

Published: December 2023

Objectives: To characterize a carbapenem-resistant Pseudomonas aeruginosa (CRPA) with an IncP-2 plasmid containing a novel transposon, Tn6485h, which carries both blaIMP-45 and blaAFM-1.

Methods: Antimicrobial susceptibility testing and filter mating experiment were performed on PA942. The stability of the plasmid carrying both blaIMP-45 and blaAFM-1 was carried out. We determined the growth rate of the transconjugant to investigate fitness cost. Additionally, whole-genome sequencing and genomic analysis were performed on PA942.

Results: PA942 strain was resistant to most antibiotics except for ciprofloxacin and colistin. Bioinformatics analysis confirmed that PA942 contains an IncP-2 plasmid with a novel transposon Tn6485h carrying both blaIMP-45 and blaAFM-1 The plasmid pPA942-IMP45 can be transferred into recipient bacteria PAO1 with an efficiency of 2.2 × 10 and the transconjugant PAO1/ pPA942-IMP45 can be stably inherited for 10 generations in the absence of antibiotics.

Conclusion: We report a carbapenem-resistant P. aeruginosa strain with an IncP-2 plasmid containing a novel transposon, Tn6485h, which carries both blaIMP-45 and blaAFM-1. The IncP-2 plasmid and transposon Tn6485h may contribute to the spread of MBL genes. Therefore, effective measures to prevent the spread of these plasmids should be taken.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgar.2023.10.010DOI Listing

Publication Analysis

Top Keywords

incp-2 plasmid
20
blaimp-45 blaafm-1
16
transposon tn6485h
16
carrying blaimp-45
12
plasmid novel
12
novel transposon
12
carbapenem-resistant pseudomonas
8
pseudomonas aeruginosa
8
tn6485h carries
8
carries blaimp-45
8

Similar Publications

Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.

J Antimicrob Chemother

July 2024

Team ReSIST, UMR1184, INSERM, Université Paris-Saclay, CEA, School of Medicine, OI HEALTHI, Le Kremlin-Bicêtre, France.

Background: Carbapenem-resistant Pseudomonas aeruginosa are being increasingly described worldwide. Here, we investigated the molecular mechanisms underlying carbapenem resistance in an extremely drug-resistant P. aeruginosa isolate from a neonatal intensive care unit in Morocco.

View Article and Find Full Text PDF
Article Synopsis
  • Recent research has focused on megaplasmids and their role in spreading antimicrobial resistance (AMR), particularly due to advancements in long-read sequencing technologies.
  • Analysis revealed that the majority of identified megaplasmids belong to the IncP-2 type, featuring conserved genetic traits and abundant AMR genes, especially those linked to serious hospital infections.
  • The study proposes that chromids, which can evolve from megaplasmids, might enable quicker genetic adaptations in response to new environments or pressures, highlighting their evolutionary significance.
View Article and Find Full Text PDF

Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of in China from 2010 to 2022.

Emerg Microbes Infect

December 2024

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.

Ceftazidime-avibactam (CZA) resistance is a huge threat in the clinic; however, the underlying mechanism responsible for high-level CZA resistance in (PA) isolates remains unknown. In this study, a total of 5,763 isolates were collected from 2010 to 2022 to investigate the ceftazidime-avibactam (CZA) high-level resistance mechanisms of (PA) isolates in China. Fifty-six PER-producing isolates were identified, including 50 isolates carrying in PA, and 6 isolates carrying .

View Article and Find Full Text PDF

Characterization of a novel Tn6485h transposon carrying both blaIMP-45 and blaAFM-1 integrated into the IncP-2 plasmid in a carbapenem-resistant Pseudomonas aeruginosa.

J Glob Antimicrob Resist

December 2023

Centre of Laboratory Medicine, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address:

Objectives: To characterize a carbapenem-resistant Pseudomonas aeruginosa (CRPA) with an IncP-2 plasmid containing a novel transposon, Tn6485h, which carries both blaIMP-45 and blaAFM-1.

Methods: Antimicrobial susceptibility testing and filter mating experiment were performed on PA942. The stability of the plasmid carrying both blaIMP-45 and blaAFM-1 was carried out.

View Article and Find Full Text PDF

Characterization of two novel VIM-type metallo-β-lactamases, VIM-84 and VIM-85, associated with the spread of IncP-2 megaplasmids in .

Microbiol Spectr

September 2023

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Article Synopsis
  • This study identifies two new metallo-β-lactamases, VIM-84 and VIM-85, which contribute to antimicrobial resistance (AMR) spread through IncP-2 type megaplasmids.
  • Both enzymes are encoded by novel genes found within class 1 integrons and exhibit stronger resistance to β-lactams compared to an existing enzyme, VIM-24.
  • The research highlights the global distribution of these megaplasmids and their role in facilitating hospital outbreaks by harboring and disseminating AMR genes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!